This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Jul 1;75(7):791-793.

doi: 10.1001/jamaneurol.2017.4029.

Gene Therapy in Alzheimer Disease-It May Be Feasible, but Will It Be Beneficial?

Lawrence S Honig^{1

2

3}

Affiliations

Affiliations

¹ Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
² The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Herbert and Florence Irving Medical Center, New York, New York.
³ GH Sergievsky Center, Columbia University Herbert and Florence Irving Medical Center, New York, New York.

PMID: 29582049
DOI: 10.1001/jamaneurol.2017.4029

Editorial

Gene Therapy in Alzheimer Disease-It May Be Feasible, but Will It Be Beneficial?

Lawrence S Honig. JAMA Neurol. 2018.

. 2018 Jul 1;75(7):791-793.

doi: 10.1001/jamaneurol.2017.4029.

Author

Lawrence S Honig^{1

2

3}

Affiliations

¹ Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
² The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Herbert and Florence Irving Medical Center, New York, New York.
³ GH Sergievsky Center, Columbia University Herbert and Florence Irving Medical Center, New York, New York.

PMID: 29582049
DOI: 10.1001/jamaneurol.2017.4029

No abstract available

PubMed Disclaimer

Comment on

Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.
Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS; AAV2-NGF Study Team. Rafii MS, et al. JAMA Neurol. 2018 Jul 1;75(7):834-841. doi: 10.1001/jamaneurol.2018.0233. JAMA Neurol. 2018. PMID: 29582053 Free PMC article. Clinical Trial.

Similar articles

Alzheimer disease: NGF gene therapy activates neurons in the AD patient brain.
Malkki H. Malkki H. Nat Rev Neurol. 2015 Oct;11(10):548. doi: 10.1038/nrneurol.2015.170. Epub 2015 Sep 8. Nat Rev Neurol. 2015. PMID: 26347367 No abstract available.
Gene therapy success for Alzheimer's?
Brown M. Brown M. Drug Discov Today. 2003 Jun 1;8(11):474-5. doi: 10.1016/s1359-6446(03)02719-3. Drug Discov Today. 2003. PMID: 12818511 No abstract available.
Do we need marker gene studies in humans to improve clinical AAV gene therapy?
Weber T. Weber T. Gene Ther. 2017 Feb;24(2):72-73. doi: 10.1038/gt.2016.84. Epub 2017 Jan 5. Gene Ther. 2017. PMID: 28054581 Free PMC article. No abstract available.
[Gene therapy for Alzheimer' s disease].
Iwata N, Ozawa K, Saido TC. Iwata N, et al. Nihon Rinsho. 2005 Mar;63(3):394-400. Nihon Rinsho. 2005. PMID: 15773336 Review. Japanese.
Targeting Alzheimer's disease with gene and cell therapies.
Loera-Valencia R, Piras A, Ismail MAM, Manchanda S, Eyjolfsdottir H, Saido TC, Johansson J, Eriksdotter M, Winblad B, Nilsson P. Loera-Valencia R, et al. J Intern Med. 2018 Jul;284(1):2-36. doi: 10.1111/joim.12759. J Intern Med. 2018. PMID: 29582495 Review.

See all similar articles

Cited by

Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
Xhima K, Markham-Coultes K, Hahn Kofoed R, Saragovi HU, Hynynen K, Aubert I. Xhima K, et al. Brain. 2022 Aug 27;145(8):2806-2822. doi: 10.1093/brain/awab460. Brain. 2022. PMID: 34919633 Free PMC article.
Intravenous and Non-invasive Drug Delivery to the Mouse Basal ForebrainUsing MRI-guided Focused Ultrasound.
Xhima K, McMahon D, Ntiri E, Goubran M, Hynynen K, Aubert I. Xhima K, et al. Bio Protoc. 2021 Jun 20;11(12):e4056. doi: 10.21769/BioProtoc.4056. eCollection 2021 Jun 20. Bio Protoc. 2021. PMID: 34262999 Free PMC article.
The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease.
Culibrk RA, Hahn MS. Culibrk RA, et al. Front Aging Neurosci. 2020 Dec 7;12:583884. doi: 10.3389/fnagi.2020.583884. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33364931 Free PMC article. Review.
Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer's disease.
Xhima K, Markham-Coultes K, Nedev H, Heinen S, Saragovi HU, Hynynen K, Aubert I. Xhima K, et al. Sci Adv. 2020 Jan 22;6(4):eaax6646. doi: 10.1126/sciadv.aax6646. eCollection 2020 Jan. Sci Adv. 2020. PMID: 32010781 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information